148 related articles for article (PubMed ID: 3211616)
1. Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities.
Demaugre F; Bonnefont JP; Mitchell G; Nguyen-Hoang N; Pelet A; Rimoldi M; Di Donato S; Saudubray JM
Pediatr Res; 1988 Sep; 24(3):308-11. PubMed ID: 3211616
[TBL] [Abstract][Full Text] [Related]
2. [Heterogeneity of carnitine palmitoyltransferase deficiencies. Deficiency of CPT I in the hepatic form and CPT II in the muscular form].
Bonnefont JP; Ogier H; Mitchell G; Demaugre F; Pelet A; Saudubray JM; Frezal J
Arch Fr Pediatr; 1985; 42 Suppl 1():613-7. PubMed ID: 4083994
[TBL] [Abstract][Full Text] [Related]
3. Immunoquantitative analysis of human carnitine palmitoyltransferase I and II defects.
Demaugre F; Bonnefont JP; Cepanec C; Scholte J; Saudubray JM; Leroux JP
Pediatr Res; 1990 May; 27(5):497-500. PubMed ID: 2345677
[TBL] [Abstract][Full Text] [Related]
4. Hepatic and muscular forms of palmitoyl carnitine transferase deficiency.
Bonnefont JP; Tein I; Saudubray JM; Demaugre F
Prog Clin Biol Res; 1990; 321():451-6. PubMed ID: 2326305
[No Abstract] [Full Text] [Related]
5. Muscle carnitine palmityltransferase deficiency: a case with enzyme deficiency in cultured fibroblasts.
DiDonato S; Cornelio F; Pacini L; Peluchetti D; Rimoldi M; Spreafico S
Ann Neurol; 1978 Nov; 4(5):465-7. PubMed ID: 736528
[TBL] [Abstract][Full Text] [Related]
6. Normal muscle CPT1 and CPT2 activities in hepatic presentation patients with CPT1 deficiency in fibroblasts. Tissue specific isoforms of CPT1?
Tein I; Demaugre F; Bonnefont JP; Saudubray JM
J Neurol Sci; 1989 Sep; 92(2-3):229-45. PubMed ID: 2809620
[TBL] [Abstract][Full Text] [Related]
7. Complementation analysis of carnitine palmitoyltransferase I and II defects.
Slama A; Brivet M; Boutron A; Legrand A; Saudubray JM; Demaugre F
Pediatr Res; 1996 Oct; 40(4):542-6. PubMed ID: 8888280
[TBL] [Abstract][Full Text] [Related]
8. Selective carnitine palmitoyltransferase deficiency in fibroblasts from a patient with muscle CPT deficiency.
Pula TP; Max SR; Zielke HR; Chacon M; Baab P; Gumbinas M; Reed WD
Ann Neurol; 1981 Aug; 10(2):196-8. PubMed ID: 7283405
[TBL] [Abstract][Full Text] [Related]
9. [Muscular carnitine-palmityl-transferase deficiency].
Rumpf KW; Kaiser H; Goebel HH; Wagner HA; Ullmann B; DiMauro S; Scheler F
Dtsch Med Wochenschr; 1983 Jul; 108(27):1058-61. PubMed ID: 6861647
[TBL] [Abstract][Full Text] [Related]
10. Partial deficiency of carnitine palmityltransferase: physiologic and biochemical consequences.
Layzer RB; Havel RJ; McIlroy MB
Neurology; 1980 Jun; 30(6):627-33. PubMed ID: 7189839
[TBL] [Abstract][Full Text] [Related]
11. Carnitine palmitoyltransferase deficiencies.
Bonnefont JP; Demaugre F; Prip-Buus C; Saudubray JM; Brivet M; Abadi N; Thuillier L
Mol Genet Metab; 1999 Dec; 68(4):424-40. PubMed ID: 10607472
[TBL] [Abstract][Full Text] [Related]
12. Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leucocytes.
Scholte HR; Jennekens FG; Bouvy JJ
J Neurol Sci; 1979 Jan; 40(1):39-51. PubMed ID: 762593
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency.
IJlst L; Mandel H; Oostheim W; Ruiter JP; Gutman A; Wanders RJ
J Clin Invest; 1998 Aug; 102(3):527-31. PubMed ID: 9691089
[TBL] [Abstract][Full Text] [Related]
14. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.
Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL
Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511
[TBL] [Abstract][Full Text] [Related]
15. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.
Bonnefont JP; Djouadi F; Prip-Buus C; Gobin S; Munnich A; Bastin J
Mol Aspects Med; 2004; 25(5-6):495-520. PubMed ID: 15363638
[TBL] [Abstract][Full Text] [Related]
16. A case of carnitine palmitoyltransferase II deficiency in human skeletal muscle.
Singh R; Shepherd IM; Derrick JP; Ramsay RR; Sherratt HS; Turnbull DM
FEBS Lett; 1988 Dec; 241(1-2):126-30. PubMed ID: 3197828
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of two mutations in carnitine palmitoyltransferase IA deficiency.
Ogawa E; Kanazawa M; Yamamoto S; Ohtsuka S; Ogawa A; Ohtake A; Takayanagi M; Kohno Y
J Hum Genet; 2002; 47(7):342-7. PubMed ID: 12111367
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
[TBL] [Abstract][Full Text] [Related]
19. Beta-oxidation enzymes in normal human muscle and in muscle from a patient with an unusual form of myopathic carnitine deficiency.
Trevisan CP; Reichmann H; DeVivo DC; DiMauro S
Muscle Nerve; 1985 Oct; 8(8):672-5. PubMed ID: 2932640
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency.
Bennett MJ; Boriack RL; Narayan S; Rutledge SL; Raff ML
Mol Genet Metab; 2004 May; 82(1):59-63. PubMed ID: 15110323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
